AATI develops, manufactures and markets low to high-throughput, fully-automated nucleic acid and genetic analysis systems. Our products have both commercial and research applications and are designed to improve processes within:

The company’s product portfolio includes instruments for the parallel analysis of biomolecules, DNA, RNA, genomic DNA, double-stranded DNA and pharmaceutical compounds using capillary electrophoresis (CE) with fluorescence detection or UV absorbance.